| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/19/1995 | EP0662827A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/19/1995 | EP0662782A1 Pp14-based therapy |
| 07/19/1995 | EP0646129A4 Receptor-type tyrosine kinase-like molecules. |
| 07/19/1995 | EP0527760B1 Methods and compositions for vaccination against hiv |
| 07/19/1995 | EP0513227B1 Monoclonal antibodies which differentiate between native and modified sequence proteins |
| 07/19/1995 | EP0424416B1 Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex |
| 07/19/1995 | EP0358739B1 Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use thereof |
| 07/19/1995 | EP0332677B1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| 07/19/1995 | EP0198015B2 Production of streptavidin-like polypeptides |
| 07/18/1995 | US5434245 Osteocalcin |
| 07/18/1995 | US5434135 Growth factor compositions, preparation and use |
| 07/18/1995 | US5434131 Chimeric CTLA4 receptor and methods for its use |
| 07/18/1995 | US5434079 Apparatus and process for continuous in vitro synthesis of proteins |
| 07/18/1995 | US5434077 Borrelia burgdorferi strain 257 |
| 07/18/1995 | US5434076 Tumor-specific, cell surface-binding monoclonal antibodies |
| 07/18/1995 | US5434075 Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses |
| 07/18/1995 | US5434073 Fibrinolytic and anti-thrombotic cleavable dimers |
| 07/18/1995 | US5434064 Expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
| 07/18/1995 | US5434060 Culture of Streptomyces |
| 07/18/1995 | US5434059 Thrombolytic agent and process of preparation thereof |
| 07/18/1995 | US5433948 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 07/18/1995 | CA1336329C Fusion proteins, a process for their preparation and their use |
| 07/18/1995 | CA1336321C Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor |
| 07/13/1995 | WO1995018866A1 Method of determining tumor immunogenicity |
| 07/13/1995 | WO1995018863A1 Composition containing nucleic acids, preparation and uses |
| 07/13/1995 | WO1995018858A1 Thrombopoietin |
| 07/13/1995 | WO1995018856A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 07/13/1995 | WO1995018853A1 Mutant luciferases |
| 07/13/1995 | WO1995018852A1 Herpesvirus replication defective mutants |
| 07/13/1995 | WO1995018826A2 Purified primate ctla-8 antigens and related reagents |
| 07/13/1995 | WO1995018825A1 Novel bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis |
| 07/13/1995 | WO1995018824A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/13/1995 | WO1995018819A1 Ligand that binds fas antigen |
| 07/13/1995 | WO1995018631A1 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |
| 07/13/1995 | WO1995016035A3 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 07/13/1995 | WO1995011919A3 Recombinant pilc proteins, process for producing them and their use |
| 07/13/1995 | WO1995008631A3 Target antigens of transmission blocking antibodies for malaria parasites |
| 07/13/1995 | WO1995006122A3 Recombinant alternaria alternata allergenes |
| 07/13/1995 | WO1995006121A3 Recombinant cladosporium herbarum allergens |
| 07/13/1995 | CA2180644A1 Novel bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis |
| 07/13/1995 | CA2180551A1 Herpesvirus replication defective mutants |
| 07/13/1995 | CA2180531A1 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |
| 07/12/1995 | EP0662516A1 Novel elafin derivative |
| 07/12/1995 | EP0662515A1 Signal sequences for secretion of heterologous proteins from yeast |
| 07/12/1995 | EP0662513A1 Methods for preventing degradation of protein C |
| 07/12/1995 | EP0662482A1 Process for preparation of human glicentin |
| 07/12/1995 | EP0662157A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 07/12/1995 | EP0662150A1 Maspin, a novel serpin with tumor suppressing activity |
| 07/12/1995 | EP0662148A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 07/12/1995 | EP0662147A1 Small cell lung carcinoma specific antibody and antigen. |
| 07/12/1995 | EP0662145A1 Process for the selective increase of production of antibiotic ge 2270 factor a. |
| 07/12/1995 | EP0662134A1 Polypeptides involved in streptogramin biosynthesis, nucleotide sequences coding for said polypeptides and use thereof |
| 07/12/1995 | EP0662133A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 07/12/1995 | EP0662132A1 Self-assembling recombinant papillomavirus capsid proteins |
| 07/12/1995 | EP0662130A1 A method of producing hepatocyte growth factor and a cell line |
| 07/12/1995 | EP0662129A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 07/12/1995 | EP0662093A1 Hiv immunotherapeutics |
| 07/12/1995 | EP0662092A1 Activity-dependent neurotrophic factor |
| 07/12/1995 | EP0662090A1 Peptide inhibitors of mitogenesis and motogenesis |
| 07/12/1995 | EP0662087A1 Retinal pigmented epithelium derived neurotrophic factor |
| 07/12/1995 | EP0662086A1 Protein l and hybrid proteins thereof |
| 07/12/1995 | EP0662077A1 Cd27 ligand |
| 07/12/1995 | EP0661999A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 07/12/1995 | EP0661990A1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 07/12/1995 | EP0661987A1 Morphogen-induced liver regeneration |
| 07/12/1995 | EP0661933A1 Morphogen-enriched dietary composition |
| 07/12/1995 | EP0316319B1 Production and use of non-glycosylated IL-6 |
| 07/12/1995 | CN1105030A Erythropoietin analogs |
| 07/12/1995 | CN1029321C Method for selectively increasing the ratio of single major components of teicoplanin A2 complex |
| 07/11/1995 | US5432157 Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect and a use thereof |
| 07/11/1995 | US5432082 Expression and secretion vector in yeasts, useful for preparing heterologous proteins |
| 07/11/1995 | US5432062 Method of proteolytically cleaving prothrombin to produce thrombin |
| 07/11/1995 | US5430935 Method for repairing a combustion chamber assembly |
| 07/11/1995 | CA1336307C Process for the preparation of a heat resistant non bitter water-soluble peptide, the product produced by the process, and nutrients, refreshments and dietetics comprising the product |
| 07/11/1995 | CA1336269C Expression of mammalian genes at high levels in host cells |
| 07/08/1995 | CA2139612A1 Novel inhibitor |
| 07/06/1995 | WO1995018380A1 Novel uses for gal4-receptor constructs |
| 07/06/1995 | WO1995018378A1 Analytical device and immunoassay with an internal control of protein a |
| 07/06/1995 | WO1995018233A1 Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
| 07/06/1995 | WO1995018232A1 Enzymatic method for synthesis of o-glycosylated amino acid or peptide or derivatives thereof |
| 07/06/1995 | WO1995018229A1 Antimicrobial proteins |
| 07/06/1995 | WO1995018228A1 Human circulating cytokine cc-1 |
| 07/06/1995 | WO1995018226A1 Tuberous sclerosis 2 gene and uses thereof |
| 07/06/1995 | WO1995018225A1 Polycystic kidney disease 1 gene and uses thereof |
| 07/06/1995 | WO1995018221A1 Gene coding for adseverins |
| 07/06/1995 | WO1995018156A1 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies |
| 07/06/1995 | WO1995017906A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 07/06/1995 | WO1995017905A1 Ileal bile acid transporter compositions and methods |
| 07/06/1995 | WO1995016038A3 Humanized antibodies and uses thereof |
| 07/06/1995 | WO1995013103A3 Soluble factor stimulation of attachment and hemidesmosome assembly in epithelial cells |
| 07/06/1995 | CA2180359A1 Ileal bile acid transporter compositions and methods |
| 07/06/1995 | CA2180271A1 Novel uses for gal4-receptor constructs |
| 07/06/1995 | CA2179908A1 Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
| 07/06/1995 | CA2179638A1 Human circulating cytokine cc-1 |
| 07/06/1995 | CA2179297A1 Analytical device and immunoassay with an internal control of protein a |
| 07/06/1995 | CA2177854A1 Antimicrobial proteins |
| 07/05/1995 | EP0660937A1 Process for the preparation of factor x depleted plasma |
| 07/05/1995 | EP0660874A1 Recombinant dnase b derived from streptococcus pyogenes |
| 07/05/1995 | EP0362218B1 IMPROVED METHOD FOR PRODUCING FACTOR VIII:c-TYPE PROTEINS |
| 07/05/1995 | CN1104773A Immunoassay for analytes in samples using alkylating agents |